A detailed history of Premier Path Wealth Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 8,685 shares of BSX stock, worth $772,530. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,685
Previous 8,719 0.39%
Holding current value
$772,530
Previous $671 Million 8.39%
% of portfolio
0.11%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$72.96 - $84.0 $2,480 - $2,856
-34 Reduced 0.39%
8,685 $728 Million
Q2 2024

Jul 24, 2024

BUY
$67.33 - $77.71 $403 - $466
6 Added 0.07%
8,719 $671 Million
Q1 2024

Apr 24, 2024

SELL
$57.6 - $68.62 $27,936 - $33,280
-485 Reduced 5.27%
8,713 $597 Million
Q4 2023

Jan 12, 2024

BUY
$48.64 - $57.81 $447,390 - $531,736
9,198 New
9,198 $514 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Premier Path Wealth Partners, LLC Portfolio

Follow Premier Path Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Path Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Path Wealth Partners, LLC with notifications on news.